{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:15:37Z","timestamp":1761718537790},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.vaccine.2016.11.073","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T11:46:33Z","timestamp":1482407193000},"page":"672-679","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection"],"prefix":"10.1016","volume":"35","author":[{"given":"Sanbao","family":"Ruan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair J.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Norris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judd E.","family":"Shellito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.11.073_b0005","doi-asserted-by":"crossref","first-page":"165rv113","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.vaccine.2016.11.073_b0010","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00216-008-2288-1","article-title":"MALDI-TOF mass signatures for differentiation of yeast species, strain grouping and monitoring of morphogenesis markers","volume":"392","author":"Qian","year":"2008","journal-title":"Anal Bioanal Chem"},{"issue":"6","key":"10.1016\/j.vaccine.2016.11.073_b0015","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1128\/IAI.01678-13","article-title":"Novel pneumocystis antigen discovery using fungal surface proteomics","volume":"82","author":"Zheng","year":"2014","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2016.11.073_b0020","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1128\/IAI.00065-08","article-title":"Interleukin-12 and host defense against murine Pneumocystis pneumonia","volume":"76","author":"Ruan","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.11.073_b0025","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1172\/JCI114621","article-title":"A new model of Pneumocystis carinii pneumonia in mice selectively depleted of helper T lymphocytes","volume":"85","author":"Shelllito","year":"1990","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.vaccine.2016.11.073_b0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0969-2126(01)00621-9","article-title":"Crystal structures of mitochondrial processing peptidase reveal the mode for specific cleavage of import signal sequences","volume":"9","author":"Taylor","year":"2001","journal-title":"Structure"},{"key":"10.1016\/j.vaccine.2016.11.073_b0040","doi-asserted-by":"crossref","first-page":"10740","DOI":"10.1038\/ncomms10740","article-title":"Genome analysis of three Pneumocystis species reveals adaptation mechanisms to life exclusively in mammalian hosts","volume":"7","author":"Ma","year":"2016","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.vaccine.2016.11.073_b0045","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1128\/IAI.66.9.4268-4273.1998","article-title":"Characterization of major surface glycoprotein genes of human Pneumocystis carinii and high-level expression of a conserved region","volume":"66","author":"Mei","year":"1998","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2016.11.073_b0050","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00428-12","article-title":"De novo assembly of the Pneumocystis jirovecii genome from a single bronchoalveolar lavage fluid specimen from a patient","volume":"4","author":"Cisse","year":"2012","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2016.11.073_b0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/yea.1709","article-title":"Yeast Ste23p shares functional similarities with mammalian insulin-degrading enzymes","volume":"26","author":"Benjamin","year":"2009","journal-title":"Yeast"},{"issue":"1","key":"10.1016\/j.vaccine.2016.11.073_b0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2217\/fmb.09.116","article-title":"Current understanding of Pneumocystis immunology","volume":"5","author":"Kelly","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2016.11.073_b0065","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1172\/JCI119384","article-title":"The role of alveolar macrophages in Pneumocystis carinii degradation and clearance from the lung","volume":"99","author":"Limper","year":"1997","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.vaccine.2016.11.073_b0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/CDLI.10.2.293-302.2003","article-title":"Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery","volume":"10","author":"Lasbury","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"29","key":"10.1016\/j.vaccine.2016.11.073_b0075","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59 \u2013 an innately attractive adjuvant formulation","volume":"30","author":"O\u2019Hagan","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2016.11.073_b0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/14760584.2.2.197","article-title":"MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile","volume":"2","author":"Podda","year":"2003","journal-title":"Expert Rev Vaccines"},{"issue":"11","key":"10.1016\/j.vaccine.2016.11.073_b0085","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1128\/IAI.65.11.4790-4794.1997","article-title":"The major surface glycoprotein of Pneumocystis carinii induces release and gene expression of interleukin-8 and tumor necrosis factor alpha in monocytes","volume":"65","author":"Benfield","year":"1997","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2016.11.073_b0090","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1128\/IAI.70.3.1069-1074.2002","article-title":"Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia","volume":"70","author":"Gigliotti","year":"2002","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2016.11.073_b0095","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1128\/IAI.66.7.3179-3182.1998","article-title":"Immunization with Pneumocystis carinii gpA is immunogenic but not protective in a mouse model of P. carinii pneumonia","volume":"66","author":"Gigliotti","year":"1998","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2016.11.073_b0100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1139\/w11-023","article-title":"Active immunization against Pneumocystis carinii with p55\u2013v3 DNA vaccine in rats","volume":"57","author":"Feng","year":"2011","journal-title":"Can J Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2016.11.073_b0105","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/QAI.0b013e3182167516","article-title":"Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia","volume":"57","author":"Gingo","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"10.1016\/j.vaccine.2016.11.073_b0110","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1172\/JCI13826","article-title":"CD4+ T cell-independent vaccination against Pneumocystis carinii in mice","volume":"108","author":"Zheng","year":"2001","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.vaccine.2016.11.073_b0115","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1172\/JCI26306","article-title":"CD4+ T cell-independent DNA vaccination against opportunistic infections","volume":"115","author":"Zheng","year":"2005","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.vaccine.2016.11.073_b0120","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1086\/597803","article-title":"Long-term serologic responses to the Pneumocystis jirovecii major surface glycoprotein in HIV-positive individuals with and without P. jirovecii infection","volume":"199","author":"Walzer","year":"2009","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16311446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16311446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T05:00:35Z","timestamp":1601269235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16311446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0264410X16311446"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.073","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B cell and antibody responses in mice induced by a putative cell surface peptidase of Pneumocystis murina protect against experimental infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}